Active, not recruitingNot applicableNCT06234488
Multi-Institutional Transgender & Gender-Diverse Breast Cancer Study
Studying Rare malignant breast tumor
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- Medical College of Wisconsin
- Principal Investigator
- Chandler S CortinaThe Medical College of Wisconsin
- Eligibility
- 18 years · All sexes
- Timeline
- 2023 – 2024
Study locations (20)
- University of Southern California/Los Angeles (USC/LA County), Los Angeles, California, United States
- University of California San Francisco (UCSF), San Francisco, California, United States
- University of Colorado Anschutz Medical Campus (CU Anschutz), Aurora, Colorado, United States
- MedStar Georgetown University Hospital (MGUH), Washington D.C., District of Columbia, United States
- Mayo Clinic, Jacksonville, Florida, United States
- Moffitt Cancer Center (MCC), Tampa, Florida, United States
- Northwestern Medicine, Chicago, Illinois, United States
- Rush University Medical Center, Chicago, Illinois, United States
- NorthShore University Health System, Evanston, Illinois, United States
- Massachusetts General Hospital, Boston, Massachusetts, United States
- Birgham and Women's Hospital, Boston, Massachusetts, United States
- Boston University (Boston U), Boston, Massachusetts, United States
- University of Michigan, Ann Arbor, Michigan, United States
- Mayo Clinic, Rochester, Minnesota, United States
- New York University (NYU), New York, New York, United States
- +5 more locations on ClinicalTrials.gov
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT06234488 on ClinicalTrials.govOther trials for Rare malignant breast tumor
Additional recruiting or active studies for the same condition.
- ACTIVE NOT RECRUITINGNANCT06255808Development of Assist Tool for Breast Examination Using the Principle of Ultrasonic SensorSeoul National University Hospital
- RECRUITINGNANCT06523452Laser Speckle Imaging During Breast ReconstructionRoyal Devon and Exeter NHS Foundation Trust
- RECRUITINGPHASE1NCT06239467First-in-Human Study of OKI-219 in Advanced Solid Tumors and Advanced Breast CancerOnKure, Inc.
- ACTIVE NOT RECRUITINGPHASE1NCT06206837A Study to Learn About Vepdegestrant When Given With PF-07220060 to People With Advanced or Metastatic Breast Cancer.Pfizer
- RECRUITINGPHASE2NCT05601440Liquid-biopsy Informed Platform Trial to Evaluate CDK4/6-inhibitor Resistant ER+/HER2- Metastatic Breast CancerCanadian Cancer Trials Group
- ENROLLING BY INVITATIONNANCT07206888Advanced Ultrasound Signal Processing of Suspicious Breast ImagesJohns Hopkins University
- ACTIVE NOT RECRUITINGPHASE3NCT01674140S1207 Hormone Therapy With or Without Everolimus in Treating Patients With Breast CancerSWOG Cancer Research Network
- ACTIVE NOT RECRUITINGPHASE3NCT01349322Higher Per Daily Treatment-Dose Radiation Therapy or Standard Per Daily Treatment Radiation Therapy in Treating Patients With Early-Stage Breast Cancer That Was Removed by SurgeryRadiation Therapy Oncology Group